Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting

Serum neurofilament light chain (sNfL) is an intensely investigated biomarker in multiple sclerosis (MS). The aim of this study was to explore the impact of cladribine (CLAD) on sNfL and the potential of sNfL as a predictor of long-term treatment response. Data were gathered from a prospective, real...

Descripción completa

Detalles Bibliográficos
Autores principales: Seiberl, Michael, Feige, Julia, Hilpold, Patrick, Hitzl, Wolfgang, Machegger, Lukas, Buchmann, Arabella, Khalil, Michael, Trinka, Eugen, Harrer, Andrea, Wipfler, Peter, Moser, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961994/
https://www.ncbi.nlm.nih.gov/pubmed/36835478
http://dx.doi.org/10.3390/ijms24044067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961994/
https://www.ncbi.nlm.nih.gov/pubmed/36835478
http://dx.doi.org/10.3390/ijms24044067

Ejemplares similares